Multiscale deep neural network based analysis of FDG-PET images for the early diagnosis of Alzheimer’s disease
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- May 01, 2018
- Source ID
- 10.1016/j.media.2018.02.002
Entities
People
- Donghuan Lu
- Gavin Weiguang Ding
- Karteek Popuri
- Mirza Faisal Beg
- Rakesh Balachandar
Organizations
- AbbVie
- Alzheimer's Association
- Alzheimer's Disease Neuroimaging Initiative
- Alzheimer's Drug Discovery Foundation
- BioClinica
- Biogen
- Brain Canada Foundation
- Bristol-Myers Squibb
- Canadian Institutes of Health Research
- Chiron Corporation
- Eisai
- Eli Lilly and Company
- GE HealthCare
- Hoffmann-La Roche
- Innogenetics
- Johnson & Johnson Pharmaceutical Research and Development
- Lundbeck
- Merck & Co.
- Meso Scale Diagnostics (United States)
- Michael Smith Foundation for Health Research
- National Institute of Biomedical Imaging and Bioengineering
- National Institute on Aging
- National Institutes of Health
- Natural Sciences and Engineering Research Council
- Pfizer
- Roche (United States)
- Takeda Pharmaceutical Company
- United States Department of Defense